Related Experiment Video
Updated: Oct 9, 2025

Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury
Published on: February 26, 2017
Rapidly progressive respiratory failure after helminth larvae ingestion
Anahit A Zeynalyan1, Balaji Kolasani2, Chetan Naik3
1Department of Internal Medicine, Baylor University Medical Center, 3500 Gaston Ave, Dallas, Texas, 75246, USA. Anahit.Zeynalyan@BSWHealth.org.
Self-administered helminth therapy for autoimmune disease led to fatal respiratory failure in a patient with systemic sclerosis. This case highlights the significant risks of unproven experimental treatments, especially for those with underlying lung conditions.
Area of Science:
- Investigating novel therapeutic approaches for autoimmune diseases.
- Evaluating the safety and efficacy of helminthic therapies.
- Understanding the immunomodulatory effects of helminths in human disease.
Background:
- Autoimmune diseases like systemic sclerosis (SSc) can lead to severe complications, including pulmonary arterial hypertension (PAH).
- Self-administration of helminths is being explored as an alternative therapy for autoimmune conditions, despite limited evidence.
- Patients with SSc and pre-existing lung conditions are particularly vulnerable to novel treatments.
Observation:
- A patient with SSc and PAH self-administered Necator americanus for treatment.
- Following helminth ingestion, the patient developed worsening respiratory symptoms, hypoxemia, and eosinophilia.
- Imaging revealed progressive interstitial lung disease (ILD) and acute lung injury.
Findings:
- Laboratory tests indicated parasitic infection with elevated IgE and IgG antibodies to Strongyloides.
- Cardiovascular assessments showed worsening PAH and right heart failure.
- Despite medical interventions, the patient's respiratory status rapidly declined.
Implications:
- Self-prescribed helminth therapy can precipitate severe, life-threatening complications.
- Experimental treatments carry significant risks, particularly in immunocompromised individuals or those with underlying organ damage.
- This case underscores the critical need for caution and rigorous scientific validation before adopting unproven therapies for autoimmune diseases.
Related Concept Videos
Acute Respiratory Failure-III
Acute Respiratory Failure-IV
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pulmonary Cycle: Exhalation
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

